NCT03127384View on ClinicalTrials.gov

Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars

PHASE4CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

February 15, 2018

Study Completion Date

November 8, 2018

Conditions

Healthy Volunteers

Interventions

DEVICE

Restylane Lidocaine

Hyaluronic acid based filler

OTHER

No-treatment control

No-treatment control

Trial Locations (2)

Unknown

Darmstadt, Darmstadt

Munich, Munich

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY